Navigation Links
Monsanto Shareowners Reelect Board Members at Company's Annual Meeting
Date:1/14/2009

ST. LOUIS, Jan. 14 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) announced today that at its annual shareowners meeting, shareowners elected four members of its board of directors to new terms:

    -- Janice L. Fields
    -- Hugh Grant
    -- C. Steven McMillan
    -- Robert J. Stevens

These members received a majority of the votes cast and were elected to serve until the company's 2012 annual meeting.

Shareowners also ratified the Board's Audit and Finance Committee's appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the 2009 fiscal year.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: http://www.monsanto.com.


'/>"/>
SOURCE Monsanto Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Monsanto Company Signs Share Subscription Agreement With Devgen
3. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
4. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
5. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
6. Science Magazine Recognizes Monsanto as Top Employer
7. Monsanto Company Executives Adopt 10b5-1 Trading Plans
8. Monsanto and Devgen Describe New Approach to Insect-Protection
9. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
10. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
11. Monsanto Executives to Address Investor Conferences in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a ... release its full financial results for the fourth quarter and ... after market close, followed by a conference call at ... outlook. Participants should call (888) 243-4451 ( ... the InspireMD call. A live webcast of the call will ...
(Date:3/6/2015)... According to a new market ... patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) ... augmentation) - Global Forecast to 2019", published by MarketsandMarkets, ... $14.7 Billion in 2019 from $10.3 Billion in 2014, ... 2019. Browse 70 market data tables ...
(Date:3/6/2015)... 06, 2015 AACC International unveiled ... for the grain scientists’ Centennial Meeting and also ... 2015 marks the 100th anniversary of AACC International ... Minneapolis, Minnesota, U.S.A. on October 18-21, 2015. The ... who are looking to the next 100 years ...
(Date:3/6/2015)... 6, 2015  Attorney Advertising-- Bronstein, Gewirtz & Grossman, ... purchasers of the securities of Orexigen Therapeutics, Inc. ... -News).  Such investors are advised to contact ... coordinator Eitan Kimelman at info@bgandg.com ... whether Orexigen and certain of its officers and/or ...
Breaking Biology Technology:InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th 2Soft Tissue Repair Market worth $14.7 Billion in 2019 2Soft Tissue Repair Market worth $14.7 Billion in 2019 3Soft Tissue Repair Market worth $14.7 Billion in 2019 4AACCI Unveils Scientific Symposia Sessions for Centennial Meeting 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Orexigen Therapeutics, Inc. 2
... , May 17 Sigma-Aldrich Corporation (Nasdaq: SIAL ) will ... 20th at 1:15 PM CDT ( 2:15 PM EDT ) ... over the Internet available at http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" ... , , ...
... May 17 TriReme Medical, Inc. (TMI) announced today that ... for its GliderXtreme™ PTA balloon catheter. GliderXtreme™ is now approved for ... balloon diameters from 2.0 – 5.0mm and in balloon lengths up ... , ...
... 17 ViroPharma Incorporated (Nasdaq: VPHM ) today ... Cinryze™ (C1 Esterase Inhibitor [Human]) in preventing and treating attacks ... Health,s online clinical trial registry, www.clinicaltrials.gov . The data ... data from the CHANGE 2 acute treatment study will be ...
Cached Biology Technology:Sigma-Aldrich Corporation to Present at the Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010 2TriReme Medical, Inc. Receives FDA 510(k) Clearance for a Broad Matrix of GliderXtreme(TM) PTA Balloon Catheter Sizes 2ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 2ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 3ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 4ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 5ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 6ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 7
(Date:3/5/2015)... 5, 2015 In Brazil , ... already using these solutions and 42 percent planning to invest ... approximately 25 percent of the companies will be investing in ... majority of companies in the region are currently opting for ... model will command significant attention in the coming years. This ...
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Global Biometrics Market Forecast and ... The market for biometric authentication systems is ... 14% till 2020 The driving forces ... security needs, government projects and constant development in ...
(Date:3/3/2015)... , March 3, 2015 ... provider of advanced cryogenic logistics solutions for ... immunotherapies, stem cells, cell lines, clinical research ... medicine, today announced the expansion of its ... Centers, ("Fred Hutch") Clinical Research Division ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... the University of Leicester has proposed an immense (1.5km) exhibition ... a vivid perspective of how quickly human activity is changing ... at a rate of a few centimetres every thousand years. ... vertically down into the sea bed to extract a sample ...
... 1 The U.S. Department of Homeland,Security ... collecting additional,fingerprints from international visitors arriving at ... change is part of the,department,s upgrade from ... facilitate legitimate travel by more accurately and,efficiently ...
... Mouse and rat brain atlases have long ... traditional brain atlases offer an incomplete map ... Reference Atlas: A Digital Color Brain Atlas ... Edition; January 2008; $195.00; 376 Pages; Paperback; ...
Cached Biology News:DHS Begins Collecting 10 Fingerprints From International Visitors at George Bush Houston Intercontinental Airport 2Book is the first high-resolution digital mouse brain atlas designed for Web applications 2
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Hepatocyte Differentiation Environment...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
...
Biology Products: